尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Jaeger Frank, Directeur Commercial. Director active across 1 company, notably Clarus Therapeutics Holdings, Inc.. Cumulatively, 1 filings have been published. Activity tracked since 11 December 2021. The latest transaction was filed on 11 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Frank Jaeger is the Chief Commercial Officer of Clarus Therapeutics Holdings, Inc. In this role, he oversees the company's commercial operations, which specialize in developing medical treatments. His business expertise enables him to provide strategic contributions to the company's development. He is committed to promoting innovation and excellence in medical services.